Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

BUY
$0.0 - $334.83 $0 - $52,903
158 Added 585.19%
185 $0
Q1 2024

May 01, 2024

SELL
$191.17 - $325.63 $10,323 - $17,584
-54 Reduced 66.67%
27 $8,000
Q4 2023

Jan 18, 2024

BUY
$160.99 - $215.69 $12,074 - $16,176
75 Added 1250.0%
81 $15,000
Q3 2023

Oct 11, 2023

BUY
$194.33 - $283.97 $1,165 - $1,703
6 New
6 $2,000
Q1 2023

Apr 17, 2023

SELL
$175.41 - $217.92 $175 - $217
-1 Reduced 4.0%
24 $5,000
Q4 2022

Jan 17, 2023

BUY
$204.38 - $296.82 $4,905 - $7,123
24 Added 2400.0%
25 $7,000
Q3 2022

Oct 21, 2022

BUY
$195.21 - $310.53 $195 - $310
1 New
1 $0

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Ronald Blue Trust, Inc. Portfolio

Follow Ronald Blue Trust, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ronald Blue Trust, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ronald Blue Trust, Inc. with notifications on news.